Studies reported that LL‐37 exhibits modulation of immune and inflammatory factor secretion in inflammatory diseases, such as chronic obstructive pulmonary disease and pneumonia,21, 22 and neutralizes LPS and thus inhibits TLR4 signaling pathway.23 Here, CAMP is linked to chronic obstructive pulmonary disease.